Beth Shafer

Director/Miembro de la Junta en

Aquinnah Pharmaceuticals, Inc.

Health Technology

Consumer Services

Perfil

Currently, Beth Shafer is Director at Aquinnah Pharmaceuticals, Inc. and Venture Partner at Mubadala Capital Ventures Europe.
Formerly, Dr. Shafer was Director at Arcellx, Inc., Chief Business Officer at Voyager Therapeutics, Inc. from 2023 to 2024, and Chief Business Officer at Scholar Rock Holding Corp.
from 2024 to 2025.
Education includes a doctorate from the University of California, graduate studies at Columbia University Vagelos College of Physicians & Surgeons, and undergraduate studies at Rutgers University, Camden.

Cargos activos de Beth Shafer

Empresas	Cargo	Inicio
Aquinnah Pharmaceuticals, Inc. Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development to modulate neurodegenerative stress granules	Director/Miembro de la Junta	-

Todos los cargos activos de Beth Shafer

Antiguos cargos conocidos de Beth Shafer.

Empresas	Cargo	Fin
SCHOLAR ROCK HOLDING CORPORATION	Corporate Officer/Principal	01/05/2025
VOYAGER THERAPEUTICS, INC.	Corporate Officer/Principal	01/01/2024
ARCELLX, INC.	Director/Miembro de la Junta	-

Ver el detalle de la experiencia de Beth Shafer.

Formación de Beth Shafer.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Beth Shafer.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	7
University of California University of California Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Voyager Therapeutics, Inc. Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system	Health Technology
Aquinnah Pharmaceuticals, Inc. Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development to modulate neurodegenerative stress granules	Health Technology
Rutgers University, Camden Rutgers University, Camden Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Arcellx, Inc. Arcellx, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies	Health Technology
Scholar Rock Holding Corp. Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia	Health Technology
Columbia University Vagelos College of Physicians & Surgeons Columbia University Vagelos College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services